Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/so-delicious-dairy-freer-issues-voluntary-recall-salted-caramel-cluster-non-dairy-frozen-dessertPublished September 15, 2026

Most affected stateHawaii 200 recalls mention this state

State: MP ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 16, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass II

AscorbiX (Buffered C) Injection, Ascorbix (30ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 40MCG/30MG/2MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0546-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 20MCG/30MG/1MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0545-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil (prostaglandin E1) 80 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0543-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil (prostaglandin E1)150 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0538-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30 mg/2 mg/0.15mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0550-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0549-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 18 mcg/1.8mg/0.2mg/0.02mg/mL, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0547-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason: Lack of Assurance of Sterility
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.

by Teva Pharmaceuticals USA

Reason: Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Choice Products LLC.

Product: Premiere Choice 3lb. Peanut Butter Cookie Dough, item 412, N…
Reason: Peanut Butter Cookie Dough may contain undeclared milk.
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Custom Foods LLC

Product: Sticky Fingers Bakeries Gluten-Free Scones, Quick & Easy Mix…
Reason: Firm received customer inquiry of why wheat is listed in the ingredient list of a product that is "Gluten Free".
Published: March 11, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.

by Breckenridge Pharmaceutical, Inc

Reason: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1

by Taro Pharmaceuticals U.S.A., Inc.

Reason: Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

CVS Health Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed By: CVS Pharmacy Inc. One CVS Drive, Woonsocket, RI 02895, NDC 59779-303-01

by Akorn, Inc.

Reason: Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Well at Walgreens Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed by: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC 0363-9050-00.

by Akorn, Inc.

Reason: Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-622-35

by Akorn, Inc.

Reason: Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC 60429-588-01) b) 500-count bottle (NDC 60429-588-05) Manufactured by Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Packaged by GSMS Incorporated, Camarillo, CA 93012

by Golden State Medical Supply Inc.

Reason: Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.
Published: March 4, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count bottles (NDC 0093-0058-05), RX only, Manufactured in Czech Republic for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19545

by Teva Pharmaceuticals USA

Reason: Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.
Published: February 26, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.

by NCS Healthcare of Kentucky Inc

Reason: Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Published: February 26, 2020
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11

by American Health Packaging

Reason: GMP Deviations: Product bottle may be absent of desiccant.
Published: February 26, 2020
Distribution: Nationwide

View recall →

Data last updated: September 16, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.